Falette N - Search Results

1

Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine.

Galmarini CM, Voorzanger N, Falette N, Jordheim L, Cros E, Puisieux A, Dumontet C. Galmarini CM, et al. Among authors: falette n. Biochem Pharmacol. 2003 Jan 1;65(1):121-9. doi: 10.1016/s0006-2952(02)01448-x. Biochem Pharmacol. 2003. PMID: 12473386

2

Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.

Galmarini CM, Clarke ML, Falette N, Puisieux A, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: falette n. Int J Cancer. 2002 Feb 1;97(4):439-45. doi: 10.1002/ijc.1628. Int J Cancer. 2002. PMID: 11802204

3

A p21/WAF1 mutation favors the appearance of drug resistance to paclitaxel in human noncancerous epithelial mammary cells.

Galmarini CM, Bouchet BP, Audoynaud C, Lamblot C, Falette N, Bertholon J, Wang Q, Beghin A, Dumontet C, Puisieux A. Galmarini CM, et al. Among authors: falette n. Int J Cancer. 2006 Jul 1;119(1):60-6. doi: 10.1002/ijc.21770. Int J Cancer. 2006. PMID: 16432835

4

Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.

Galmarini CM, Falette N, Tabone E, Levrat C, Britten R, Voorzanger-Rousselot N, Roesch-Gateau O, Vanier-Viornery A, Puisieux A, Dumontet C. Galmarini CM, et al. Among authors: falette n. Br J Cancer. 2001 Sep 14;85(6):902-8. doi: 10.1054/bjoc.2001.2017. Br J Cancer. 2001. PMID: 11556844 Free PMC article.

5

Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics.

Galmarini CM, Kamath K, Vanier-Viornery A, Hervieu V, Peiller E, Falette N, Puisieux A, Ann Jordan M, Dumontet C. Galmarini CM, et al. Among authors: falette n. Br J Cancer. 2003 Jun 2;88(11):1793-9. doi: 10.1038/sj.bjc.6600960. Br J Cancer. 2003. PMID: 12771997 Free PMC article.

6

p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours.

Guillot C, Falette N, Paperin MP, Courtois S, Gentil-Perret A, Treilleux I, Ozturk M, Puisieux A. Guillot C, et al. Among authors: falette n. Oncogene. 1997 Jan 9;14(1):45-52. doi: 10.1038/sj.onc.1200803. Oncogene. 1997. PMID: 9010231

7

BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.

el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD, Puisieux A. el-Ghissassi F, et al. Among authors: falette n. Oncogene. 2002 Oct 3;21(44):6772-78. doi: 10.1038/sj.onc.1205888. Oncogene. 2002. PMID: 12360398

8

Alteration of p53 damage response by tamoxifen treatment.

Guillot C, Falette N, Courtois S, Voeltzel T, Garcia E, Ozturk M, Puisieux A. Guillot C, et al. Among authors: falette n. Clin Cancer Res. 1996 Sep;2(9):1439-44. Clin Cancer Res. 1996. PMID: 9816318

9

Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype.

Bouchet BP, Bertholon J, Falette N, Audoynaud C, Lamblot C, Puisieux A, Galmarini CM. Bouchet BP, et al. Among authors: falette n. Br J Cancer. 2007 Nov 5;97(9):1218-24. doi: 10.1038/sj.bjc.6603936. Epub 2007 Oct 30. Br J Cancer. 2007. PMID: 17968427 Free PMC article.

10

BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.

Cortes U, Moyret-Lalle C, Falette N, Duriez C, Ghissassi FE, Barnas C, Morel AP, Hainaut P, Magaud JP, Puisieux A. Cortes U, et al. Among authors: falette n. Mol Carcinog. 2000 Feb;27(2):57-64. Mol Carcinog. 2000. PMID: 10657898

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters